Taxonomy,Concept,Unit,Value,Start,End,Accession,Fiscal Year,Fiscal Period,Form,Filed Date,Frame,Ticker
dei,EntityCommonStockSharesOutstanding,shares,382073208.0,,2024-02-16,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
dei,EntityCommonStockSharesOutstanding,shares,383239726.0,,2024-04-26,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
dei,EntityPublicFloat,USD,40200000000.0,,2023-06-30,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q2I,MRNA
us-gaap,AccountsPayableCurrent,USD,487000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AccountsPayableCurrent,USD,520000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AccountsPayableCurrent,USD,520000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AccountsPayableCurrent,USD,183000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AccountsReceivableGross,USD,1385000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AccountsReceivableGross,USD,1584000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AccountsReceivableGross,USD,1584000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AccountsReceivableGross,USD,422000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AccountsReceivableNet,USD,1385000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AccountsReceivableNet,USD,892000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AccountsReceivableNet,USD,892000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AccountsReceivableNet,USD,137000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AccountsReceivableNetCurrent,USD,1385000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AccountsReceivableNetCurrent,USD,892000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AccountsReceivableNetCurrent,USD,892000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AccountsReceivableNetCurrent,USD,137000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AccruedLiabilitiesCurrent,USD,2101000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AccruedLiabilitiesCurrent,USD,1798000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AccruedLiabilitiesCurrent,USD,1798000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AccruedLiabilitiesCurrent,USD,1396000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AccruedRoyaltiesCurrent,USD,203000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AccruedRoyaltiesCurrent,USD,122000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AccruedRoyaltiesCurrent,USD,122000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AccruedRoyaltiesCurrent,USD,8000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AccumulatedOtherComprehensiveIncomeLossNetOfTax,USD,-370000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AccumulatedOtherComprehensiveIncomeLossNetOfTax,USD,-123000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AccumulatedOtherComprehensiveIncomeLossNetOfTax,USD,-123000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AccumulatedOtherComprehensiveIncomeLossNetOfTax,USD,-101000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AdditionalPaidInCapital,USD,1173000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AdditionalPaidInCapital,USD,371000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AdditionalPaidInCapital,USD,371000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AdditionalPaidInCapital,USD,487000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,USD,142000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,USD,226000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,USD,75000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,USD,305000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,USD,101000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,AdvertisingExpense,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,AdvertisingExpense,USD,121000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,AdvertisingExpense,USD,204000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,AllocatedShareBasedCompensationExpense,USD,142000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,AllocatedShareBasedCompensationExpense,USD,226000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,AllocatedShareBasedCompensationExpense,USD,75000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,AllocatedShareBasedCompensationExpense,USD,305000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,AllocatedShareBasedCompensationExpense,USD,101000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,AllowanceForDoubtfulAccountsReceivableCurrent,USD,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AllowanceForDoubtfulAccountsReceivableCurrent,USD,0.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,shares,1000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,shares,3000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,shares,5000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,shares,31000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,shares,35000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,AssetImpairmentCharges,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,AssetImpairmentCharges,USD,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,AssetImpairmentCharges,USD,0.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,Assets,USD,25858000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,Assets,USD,18426000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,Assets,USD,18426000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,Assets,USD,16729000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AssetsCurrent,USD,13431000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AssetsCurrent,USD,10325000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AssetsCurrent,USD,10325000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AssetsCurrent,USD,9600000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AvailableForSaleDebtSecuritiesAmortizedCostBasis,USD,15479000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AvailableForSaleDebtSecuritiesAmortizedCostBasis,USD,10519000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AvailableForSaleDebtSecuritiesAmortizedCostBasis,USD,10519000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AvailableForSaleDebtSecuritiesAmortizedCostBasis,USD,10232000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost,USD,8687000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost,USD,4768000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost,USD,4768000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost,USD,3696000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue,USD,8318000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue,USD,4677000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue,USD,4677000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue,USD,3638000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate,USD,15015000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate,USD,10374000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate,USD,10374000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate,USD,10110000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost,USD,6792000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost,USD,5751000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost,USD,5751000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost,USD,6536000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue,USD,6697000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue,USD,5697000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue,USD,5697000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue,USD,6472000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtSecuritiesCurrent,USD,6697000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtSecuritiesCurrent,USD,5697000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtSecuritiesCurrent,USD,5697000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtSecuritiesCurrent,USD,6472000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtSecuritiesNoncurrent,USD,8318000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,AvailableForSaleSecuritiesDebtSecuritiesNoncurrent,USD,4677000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtSecuritiesNoncurrent,USD,4677000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,AvailableForSaleSecuritiesDebtSecuritiesNoncurrent,USD,3638000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,CapitalExpendituresIncurredButNotYetPaid,USD,111000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,CapitalExpendituresIncurredButNotYetPaid,USD,72000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,CapitalExpendituresIncurredButNotYetPaid,USD,98000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,CapitalExpendituresIncurredButNotYetPaid,USD,130000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,CapitalExpendituresIncurredButNotYetPaid,USD,91000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,CashAndCashEquivalentsAtCarryingValue,USD,6848000000.0,,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021Q4I,MRNA
us-gaap,CashAndCashEquivalentsAtCarryingValue,USD,3205000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,CashAndCashEquivalentsAtCarryingValue,USD,3441000000.0,,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1I,MRNA
us-gaap,CashAndCashEquivalentsAtCarryingValue,USD,2907000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,CashAndCashEquivalentsAtCarryingValue,USD,2907000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,CashAndCashEquivalentsAtCarryingValue,USD,2051000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,USD,2636000000.0,,2020-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2020Q4I,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,USD,6860000000.0,,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021Q4I,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,USD,3217000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,USD,3217000000.0,,2022-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,USD,3461000000.0,,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1I,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,USD,2928000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,USD,2928000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,USD,2071000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,USD,4224000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,USD,-3643000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,USD,244000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,USD,-289000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,USD,-857000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,CommonStockParOrStatedValuePerShare,USD/shares,0.0001,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,CommonStockParOrStatedValuePerShare,USD/shares,0.0001,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,CommonStockParOrStatedValuePerShare,USD/shares,0.0001,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,CommonStockParOrStatedValuePerShare,USD/shares,0.0001,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,CommonStockSharesAuthorized,shares,1600000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,CommonStockSharesAuthorized,shares,1600000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,CommonStockSharesAuthorized,shares,1600000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,CommonStockSharesAuthorized,shares,1600000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,CommonStockSharesIssued,shares,385000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,CommonStockSharesIssued,shares,382000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,CommonStockSharesIssued,shares,382000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,CommonStockSharesIssued,shares,383000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,CommonStockSharesOutstanding,shares,385000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,CommonStockSharesOutstanding,shares,382000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,CommonStockSharesOutstanding,shares,382000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,CommonStockSharesOutstanding,shares,383000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,CommonStockValue,USD,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,CommonStockValue,USD,0.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,CommonStockValue,USD,0.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,CommonStockValue,USD,0.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,ComprehensiveIncomeNetOfTax,USD,12175000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ComprehensiveIncomeNetOfTax,USD,8016000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ComprehensiveIncomeNetOfTax,USD,182000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,ComprehensiveIncomeNetOfTax,USD,-4467000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ComprehensiveIncomeNetOfTax,USD,-1153000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,ContractWithCustomerLiability,USD,2711000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,ContractWithCustomerLiability,USD,651000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,ContractWithCustomerLiability,USD,651000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,ContractWithCustomerLiability,USD,617000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress,USD,548000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress,USD,17000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,ContractWithCustomerLiabilityCurrent,USD,2038000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,ContractWithCustomerLiabilityCurrent,USD,568000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,ContractWithCustomerLiabilityCurrent,USD,568000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,ContractWithCustomerLiabilityCurrent,USD,559000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,ContractWithCustomerLiabilityNoncurrent,USD,673000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,ContractWithCustomerLiabilityNoncurrent,USD,83000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,ContractWithCustomerLiabilityNoncurrent,USD,83000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,ContractWithCustomerLiabilityNoncurrent,USD,58000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,ContractWithCustomerLiabilityRevenueRecognized,USD,76000000.0,2022-07-01,2022-09-30,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q3,MRNA
us-gaap,ContractWithCustomerRefundLiability,USD,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,ContractWithCustomerRefundLiability,USD,556000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,ContractWithCustomerRefundLiability,USD,556000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,ContractWithCustomerRefundLiability,USD,574000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,CostOfGoodsAndServicesSold,USD,2617000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,CostOfGoodsAndServicesSold,USD,5416000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,CostOfGoodsAndServicesSold,USD,792000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,CostOfGoodsAndServicesSold,USD,4693000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,CostOfGoodsAndServicesSold,USD,96000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,CostsAndExpenses,USD,5175000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,CostsAndExpenses,USD,9843000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,CostsAndExpenses,USD,2228000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,CostsAndExpenses,USD,11087000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,CostsAndExpenses,USD,1433000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,CurrentFederalTaxExpenseBenefit,USD,1304000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,CurrentFederalTaxExpenseBenefit,USD,1687000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,CurrentFederalTaxExpenseBenefit,USD,-225000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,CurrentForeignTaxExpenseBenefit,USD,40000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,CurrentForeignTaxExpenseBenefit,USD,57000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,CurrentForeignTaxExpenseBenefit,USD,24000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,CurrentIncomeTaxExpenseBenefit,USD,1379000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,CurrentIncomeTaxExpenseBenefit,USD,1791000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,CurrentIncomeTaxExpenseBenefit,USD,-129000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,CurrentStateAndLocalTaxExpenseBenefit,USD,35000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,CurrentStateAndLocalTaxExpenseBenefit,USD,47000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,CurrentStateAndLocalTaxExpenseBenefit,USD,72000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,DebtSecuritiesAvailableForSaleAllowanceForCreditLoss,USD,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleAllowanceForCreditLoss,USD,0.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleAllowanceForCreditLoss,USD,0.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleAllowanceForCreditLoss,USD,0.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded,USD,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded,USD,0.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded,USD,0.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded,USD,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger,USD,223000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger,USD,147000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger,USD,147000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger,USD,114000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss,USD,5524000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss,USD,6644000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss,USD,6644000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss,USD,5099000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months,USD,241000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months,USD,4000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months,USD,4000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months,USD,11000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss,USD,7635000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss,USD,1369000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss,USD,1369000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss,USD,3669000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPosition,USD,464000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPosition,USD,151000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPosition,USD,151000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPosition,USD,125000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss,USD,13159000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss,USD,8013000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss,USD,8013000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss,USD,8768000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions,security,582.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions,security,392.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions,security,392.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions,security,395.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,DeferredFederalIncomeTaxExpenseBenefit,USD,-288000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,DeferredFederalIncomeTaxExpenseBenefit,USD,-569000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,DeferredFederalIncomeTaxExpenseBenefit,USD,888000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,DeferredForeignIncomeTaxExpenseBenefit,USD,-2000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,DeferredForeignIncomeTaxExpenseBenefit,USD,-2000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,DeferredForeignIncomeTaxExpenseBenefit,USD,5000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,DeferredIncomeTaxAssetsNet,USD,982000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredIncomeTaxAssetsNet,USD,81000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,DeferredIncomeTaxAssetsNet,USD,81000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,DeferredIncomeTaxAssetsNet,USD,81000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,DeferredIncomeTaxExpenseBenefit,USD,-296000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,DeferredIncomeTaxExpenseBenefit,USD,-578000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,DeferredIncomeTaxExpenseBenefit,USD,901000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,DeferredIncomeTaxLiabilities,USD,229000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredIncomeTaxLiabilities,USD,388000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredStateAndLocalIncomeTaxExpenseBenefit,USD,-6000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,DeferredStateAndLocalIncomeTaxExpenseBenefit,USD,-7000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,DeferredStateAndLocalIncomeTaxExpenseBenefit,USD,8000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,DeferredTaxAssetsGross,USD,1366000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsGross,USD,2678000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsInventory,USD,86000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsInventory,USD,250000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsLiabilitiesNet,USD,982000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsLiabilitiesNet,USD,66000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsNet,USD,1211000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsNet,USD,454000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsOperatingLossCarryforwards,USD,59000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsOperatingLossCarryforwards,USD,90000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsOther,USD,85000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsOther,USD,90000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsOtherComprehensiveLoss,USD,106000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsOtherComprehensiveLoss,USD,34000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsTaxCreditCarryforwards,USD,97000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsTaxCreditCarryforwards,USD,140000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,USD,68000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,USD,111000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances,USD,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances,USD,129000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxAssetsValuationAllowance,USD,823000000.0,,2020-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2020Q4I,MRNA
us-gaap,DeferredTaxAssetsValuationAllowance,USD,149000000.0,,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021Q4I,MRNA
us-gaap,DeferredTaxAssetsValuationAllowance,USD,155000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxAssetsValuationAllowance,USD,2224000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxLiabilitiesOther,USD,1000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxLiabilitiesOther,USD,15000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DeferredTaxLiabilitiesPropertyPlantAndEquipment,USD,85000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,DeferredTaxLiabilitiesPropertyPlantAndEquipment,USD,107000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,DepreciationDepletionAndAmortization,USD,78000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,DepreciationDepletionAndAmortization,USD,617000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,DepreciationDepletionAndAmortization,USD,35000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,EarningsPerShareBasic,USD/shares,30.31,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EarningsPerShareBasic,USD/shares,21.26,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EarningsPerShareBasic,USD/shares,0.2,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,EarningsPerShareBasic,USD/shares,-12.33,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EarningsPerShareBasic,USD/shares,-3.07,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,EarningsPerShareDiluted,USD/shares,28.29,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EarningsPerShareDiluted,USD/shares,20.12,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EarningsPerShareDiluted,USD/shares,0.19,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,EarningsPerShareDiluted,USD/shares,-12.33,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EarningsPerShareDiluted,USD/shares,-3.07,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,EffectiveIncomeTaxRateContinuingOperations,pure,0.081,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EffectiveIncomeTaxRateContinuingOperations,pure,0.127,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EffectiveIncomeTaxRateContinuingOperations,pure,1.259,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,EffectiveIncomeTaxRateContinuingOperations,pure,-0.196,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EffectiveIncomeTaxRateContinuingOperations,pure,-0.009,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,pure,0.21,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,pure,0.21,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,pure,0.21,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,pure,-0.054,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,pure,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,pure,-0.526,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationFdiiPercent,pure,0.048,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationFdiiPercent,pure,0.074,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationFdiiPercent,pure,-0.002,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,pure,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,pure,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,pure,-0.004,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationOtherAdjustments,pure,0.001,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationOtherAdjustments,pure,0.008,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationOtherAdjustments,pure,-0.005,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent,pure,-0.026,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent,pure,-0.016,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent,pure,0.024,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,pure,0.005,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,pure,0.004,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,pure,0.057,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,pure,0.007,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,pure,0.005,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,pure,-0.046,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EmployeeRelatedLiabilitiesCurrent,USD,190000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,EmployeeRelatedLiabilitiesCurrent,USD,245000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,EmployeeRelatedLiabilitiesCurrent,USD,245000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,EmployeeRelatedLiabilitiesCurrent,USD,95000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,USD,835000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,USD,1200000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions,USD,325000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions,USD,144000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions,USD,84000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EquityMethodInvestments,USD,42000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,EquityMethodInvestments,USD,66000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,EquityMethodInvestments,USD,66000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,EquityMethodInvestments,USD,53000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,EquitySecuritiesFvNiRealizedGainLoss,USD,-35000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,EquitySecuritiesWithoutReadilyDeterminableFairValueAmount,USD,42000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,EquitySecuritiesWithoutReadilyDeterminableFairValueAmount,USD,42000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,EquitySecuritiesWithoutReadilyDeterminableFairValueAmount,USD,42000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,EquitySecuritiesWithoutReadilyDeterminableFairValueAmount,USD,42000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseInterestExpense,USD,17000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,FinanceLeaseInterestExpense,USD,29000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,FinanceLeaseInterestExpense,USD,38000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,FinanceLeaseInterestPaymentOnLiability,USD,14000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,FinanceLeaseInterestPaymentOnLiability,USD,25000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,FinanceLeaseInterestPaymentOnLiability,USD,39000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,FinanceLeaseLiability,USD,575000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FinanceLeaseLiability,USD,575000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseLiabilityCurrent,USD,161000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,FinanceLeaseLiabilityCurrent,USD,0.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,FinanceLeaseLiabilityNoncurrent,USD,912000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,FinanceLeaseLiabilityNoncurrent,USD,575000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,FinanceLeaseLiabilityNoncurrent,USD,575000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,FinanceLeaseLiabilityNoncurrent,USD,575000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDue,USD,1184000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDue,USD,1178000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths,USD,20000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive,USD,1074000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueInRollingYearFive,USD,23000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueInRollingYearFour,USD,23000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueInRollingYearThree,USD,22000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueInRollingYearTwo,USD,22000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueNextTwelveMonths,USD,22000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueYearFour,USD,23000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueYearThree,USD,23000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsDueYearTwo,USD,22000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear,USD,14000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseLiabilityUndiscountedExcessAmount,USD,609000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FinanceLeaseLiabilityUndiscountedExcessAmount,USD,603000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeasePrincipalPayments,USD,140000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,FinanceLeasePrincipalPayments,USD,184000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,FinanceLeasePrincipalPayments,USD,292000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,FinanceLeaseRightOfUseAsset,USD,1150000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,FinanceLeaseRightOfUseAsset,USD,436000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,FinanceLeaseRightOfUseAsset,USD,436000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,FinanceLeaseRightOfUseAsset,USD,433000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,FinanceLeaseRightOfUseAssetAmortization,USD,189000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,FinanceLeaseRightOfUseAssetAmortization,USD,280000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,FinanceLeaseRightOfUseAssetAmortization,USD,500000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,FinanceLeaseWeightedAverageDiscountRatePercent,pure,0.036,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,FinanceLeaseWeightedAverageDiscountRatePercent,pure,0.042,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,FiniteLivedIntangibleAssetsNet,USD,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,FiniteLivedIntangibleAssetsNet,USD,44000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,FiniteLivedIntangibleAssetsNet,USD,44000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,FiniteLivedIntangibleAssetsNet,USD,43000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,GeneralAndAdministrativeExpense,USD,567000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,GeneralAndAdministrativeExpense,USD,1132000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,GeneralAndAdministrativeExpense,USD,305000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,GeneralAndAdministrativeExpense,USD,1549000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,GeneralAndAdministrativeExpense,USD,274000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,Goodwill,USD,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,Goodwill,USD,52000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,Goodwill,USD,52000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,Goodwill,USD,52000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,USD,13108000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,USD,9433000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,USD,-4056000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,USD,13285000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,USD,9575000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,USD,-305000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,USD,-3942000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,USD,-1165000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,USD,177000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,USD,142000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,USD,114000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions,USD,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions,USD,-18000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions,USD,-35000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions,USD,-13000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncomeTaxExpenseBenefit,USD,1083000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncomeTaxExpenseBenefit,USD,1213000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncomeTaxExpenseBenefit,USD,-384000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncomeTaxExpenseBenefit,USD,772000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncomeTaxExpenseBenefit,USD,10000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncomeTaxesPaidNet,USD,480000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncomeTaxesPaidNet,USD,2729000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncomeTaxesPaidNet,USD,-357000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncomeTaxesReceivable,USD,10000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,IncomeTaxesReceivable,USD,19000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,IncomeTaxesReceivable,USD,19000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,IncomeTaxesReceivable,USD,93000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,IncreaseDecreaseInAccountsPayable,USD,204000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncreaseDecreaseInAccountsPayable,USD,240000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncreaseDecreaseInAccountsPayable,USD,-117000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncreaseDecreaseInAccountsPayable,USD,13000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncreaseDecreaseInAccountsPayable,USD,-303000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncreaseDecreaseInAccountsReceivable,USD,1784000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncreaseDecreaseInAccountsReceivable,USD,-1790000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncreaseDecreaseInAccountsReceivable,USD,-272000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncreaseDecreaseInAccountsReceivable,USD,-493000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncreaseDecreaseInAccountsReceivable,USD,-755000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncreaseDecreaseInAccruedIncomeTaxesPayable,USD,876000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncreaseDecreaseInAccruedIncomeTaxesPayable,USD,-828000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncreaseDecreaseInAccruedIncomeTaxesPayable,USD,18000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncreaseDecreaseInAccruedIncomeTaxesPayable,USD,15000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncreaseDecreaseInAccruedIncomeTaxesPayable,USD,-11000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncreaseDecreaseInAccruedLiabilities,USD,989000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncreaseDecreaseInAccruedLiabilities,USD,612000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncreaseDecreaseInAccruedLiabilities,USD,-495000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncreaseDecreaseInAccruedLiabilities,USD,-340000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncreaseDecreaseInAccruedLiabilities,USD,-398000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncreaseDecreaseInContractWithCustomerLiability,USD,2824000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncreaseDecreaseInContractWithCustomerLiability,USD,-4157000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncreaseDecreaseInContractWithCustomerLiability,USD,-819000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncreaseDecreaseInContractWithCustomerLiability,USD,-2060000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncreaseDecreaseInContractWithCustomerLiability,USD,-33000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncreaseDecreaseInInventories,USD,1394000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncreaseDecreaseInInventories,USD,-492000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncreaseDecreaseInInventories,USD,-216000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncreaseDecreaseInInventories,USD,-747000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncreaseDecreaseInInventories,USD,93000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncreaseDecreaseInOperatingLeaseLiability,USD,17000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncreaseDecreaseInOperatingLeaseLiability,USD,-14000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncreaseDecreaseInOperatingLeaseLiability,USD,4000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncreaseDecreaseInOperatingLeaseLiability,USD,551000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncreaseDecreaseInOperatingLeaseLiability,USD,-6000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncreaseDecreaseInOtherOperatingLiabilities,USD,123000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncreaseDecreaseInOtherOperatingLiabilities,USD,88000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncreaseDecreaseInOtherOperatingLiabilities,USD,-15000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncreaseDecreaseInOtherOperatingLiabilities,USD,73000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncreaseDecreaseInOtherOperatingLiabilities,USD,130000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,USD,489000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,USD,1699000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,USD,212000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,USD,-974000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,USD,-3000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,InterestPaidNet,USD,14000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,InterestPaidNet,USD,25000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,InterestPaidNet,USD,39000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,InterestReceivableCurrent,USD,61000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,InterestReceivableCurrent,USD,59000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,InterestReceivableCurrent,USD,59000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,InterestReceivableCurrent,USD,62000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,InventoryFinishedGoodsNetOfReserves,USD,169000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,InventoryFinishedGoodsNetOfReserves,USD,24000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,InventoryFinishedGoodsNetOfReserves,USD,24000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,InventoryFinishedGoodsNetOfReserves,USD,20000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,InventoryFirmPurchaseCommitmentLoss,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,InventoryFirmPurchaseCommitmentLoss,USD,617000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,InventoryFirmPurchaseCommitmentLoss,USD,66000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,InventoryFirmPurchaseCommitmentLoss,USD,141000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,InventoryFirmPurchaseCommitmentLoss,USD,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,InventoryGross,USD,1900000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,InventoryGross,USD,372000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,InventoryGross,USD,372000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,InventoryGross,USD,440000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,InventoryNet,USD,949000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,InventoryNet,USD,202000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,InventoryNet,USD,202000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,InventoryNet,USD,295000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,InventoryNoncurrent,USD,910000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,InventoryNoncurrent,USD,170000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,InventoryNoncurrent,USD,170000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,InventoryNoncurrent,USD,145000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,InventoryRawMaterialsNetOfReserves,USD,575000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,InventoryRawMaterialsNetOfReserves,USD,163000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,InventoryRawMaterialsNetOfReserves,USD,163000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,InventoryRawMaterialsNetOfReserves,USD,215000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,InventoryWorkInProcessNetOfReserves,USD,205000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,InventoryWorkInProcessNetOfReserves,USD,15000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,InventoryWorkInProcessNetOfReserves,USD,15000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,InventoryWorkInProcessNetOfReserves,USD,60000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,InventoryWriteDown,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,InventoryWriteDown,USD,1300000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,InventoryWriteDown,USD,148000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,InventoryWriteDown,USD,2200000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,InventoryWriteDown,USD,30000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,InvestmentIncomeInterest,USD,18000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,InvestmentIncomeInterest,USD,200000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,InvestmentIncomeInterest,USD,109000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,InvestmentIncomeInterest,USD,421000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,InvestmentIncomeInterest,USD,120000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,InvestmentIncomeNetAmortizationOfDiscountAndPremium,USD,-54000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,InvestmentIncomeNetAmortizationOfDiscountAndPremium,USD,-31000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,InvestmentIncomeNetAmortizationOfDiscountAndPremium,USD,17000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,InvestmentIncomeNetAmortizationOfDiscountAndPremium,USD,61000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,InvestmentIncomeNetAmortizationOfDiscountAndPremium,USD,27000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDue,USD,1133000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDue,USD,1115000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive,USD,785000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive,USD,72000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour,USD,70000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree,USD,67000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo,USD,67000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths,USD,72000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,USD,67000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,USD,72000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,USD,70000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,USD,67000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,USD,55000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,USD,465000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,USD,453000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,Liabilities,USD,6735000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,Liabilities,USD,4572000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,Liabilities,USD,4572000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,Liabilities,USD,3912000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,LiabilitiesAndStockholdersEquity,USD,25858000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,LiabilitiesAndStockholdersEquity,USD,18426000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,LiabilitiesAndStockholdersEquity,USD,18426000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,LiabilitiesAndStockholdersEquity,USD,16729000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,LiabilitiesCurrent,USD,4923000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,LiabilitiesCurrent,USD,3015000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,LiabilitiesCurrent,USD,3015000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,LiabilitiesCurrent,USD,2380000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,NetCashProvidedByUsedInFinancingActivities,USD,-873000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,NetCashProvidedByUsedInFinancingActivities,USD,-3448000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,NetCashProvidedByUsedInFinancingActivities,USD,-542000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,NetCashProvidedByUsedInFinancingActivities,USD,-1377000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,NetCashProvidedByUsedInFinancingActivities,USD,14000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,NetCashProvidedByUsedInInvestingActivities,USD,-8523000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,NetCashProvidedByUsedInInvestingActivities,USD,-5176000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,NetCashProvidedByUsedInInvestingActivities,USD,2011000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,NetCashProvidedByUsedInInvestingActivities,USD,4206000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,NetCashProvidedByUsedInInvestingActivities,USD,118000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,NetCashProvidedByUsedInOperatingActivities,USD,13620000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,NetCashProvidedByUsedInOperatingActivities,USD,4981000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,NetCashProvidedByUsedInOperatingActivities,USD,-1225000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,NetCashProvidedByUsedInOperatingActivities,USD,-3118000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,NetCashProvidedByUsedInOperatingActivities,USD,-989000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,NetIncomeLoss,USD,12202000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,NetIncomeLoss,USD,8362000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,NetIncomeLoss,USD,79000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,NetIncomeLoss,USD,-4714000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,NetIncomeLoss,USD,-1175000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,NotesAndLoansReceivableNetCurrent,USD,36000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,NotesAndLoansReceivableNetCurrent,USD,0.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,NumberOfOperatingSegments,segment,1.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OperatingIncomeLoss,USD,13296000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OperatingIncomeLoss,USD,9420000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OperatingIncomeLoss,USD,-366000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OperatingIncomeLoss,USD,-4239000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OperatingIncomeLoss,USD,-1266000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OperatingLeaseCost,USD,24000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OperatingLeaseCost,USD,48000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OperatingLeaseCost,USD,88000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OperatingLeaseLiability,USD,668000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,OperatingLeaseLiability,USD,662000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OperatingLeaseLiabilityCurrent,USD,35000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OperatingLeaseLiabilityCurrent,USD,25000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OperatingLeaseLiabilityCurrent,USD,25000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OperatingLeaseLiabilityCurrent,USD,25000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OperatingLeaseLiabilityNoncurrent,USD,92000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OperatingLeaseLiabilityNoncurrent,USD,643000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OperatingLeaseLiabilityNoncurrent,USD,643000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OperatingLeaseLiabilityNoncurrent,USD,637000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OperatingLeasePayments,USD,19000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OperatingLeasePayments,USD,57000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OperatingLeasePayments,USD,93000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OperatingLeaseRightOfUseAsset,USD,121000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OperatingLeaseRightOfUseAsset,USD,713000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OperatingLeaseRightOfUseAsset,USD,713000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OperatingLeaseRightOfUseAsset,USD,697000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OperatingLeaseWeightedAverageDiscountRatePercent,pure,0.075,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OperatingLeaseWeightedAverageDiscountRatePercent,pure,0.075,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,OtherAssetsCurrent,USD,44000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OtherAssetsCurrent,USD,88000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OtherAssetsCurrent,USD,88000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OtherAssetsCurrent,USD,68000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OtherAssetsMiscellaneousNoncurrent,USD,24000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OtherAssetsMiscellaneousNoncurrent,USD,7000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OtherAssetsMiscellaneousNoncurrent,USD,11000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OtherAssetsMiscellaneousNoncurrent,USD,35000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OtherAssetsNoncurrent,USD,988000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OtherAssetsNoncurrent,USD,685000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OtherAssetsNoncurrent,USD,685000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OtherAssetsNoncurrent,USD,650000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,USD,-43000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,USD,-322000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,USD,95000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,USD,248000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,USD,22000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent,USD,16000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent,USD,-24000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent,USD,8000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent,USD,8000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent,USD,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax,USD,74000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax,USD,130000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax,USD,0.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax,USD,0.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax,USD,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax,USD,58000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax,USD,154000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax,USD,-8000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax,USD,-8000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax,USD,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,USD,-27000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,USD,-346000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,USD,103000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,USD,247000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,USD,22000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax,USD,1000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax,USD,-26000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax,USD,-16000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax,USD,-38000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax,USD,-2000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax,USD,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax,USD,-9000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,USD,-42000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,USD,-348000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,USD,79000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,USD,210000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,USD,20000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OtherDepreciationAndAmortization,USD,232000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherDepreciationAndAmortization,USD,348000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherDepreciationAndAmortization,USD,78000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherDepreciationAndAmortization,USD,621000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherDepreciationAndAmortization,USD,36000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OtherLiabilitiesCurrent,USD,249000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OtherLiabilitiesCurrent,USD,66000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OtherLiabilitiesCurrent,USD,66000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OtherLiabilitiesCurrent,USD,190000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OtherLiabilitiesNoncurrent,USD,135000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OtherLiabilitiesNoncurrent,USD,256000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OtherLiabilitiesNoncurrent,USD,256000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OtherLiabilitiesNoncurrent,USD,262000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OtherNoncashIncomeExpense,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherNoncashIncomeExpense,USD,-28000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherNoncashIncomeExpense,USD,4000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherNoncashIncomeExpense,USD,-7000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherNoncashIncomeExpense,USD,-3000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OtherNonoperatingIncomeExpense,USD,-29000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,OtherNonoperatingIncomeExpense,USD,-45000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,OtherNonoperatingIncomeExpense,USD,-48000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,OtherNonoperatingIncomeExpense,USD,-124000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,OtherNonoperatingIncomeExpense,USD,-19000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,OtherPrepaidExpenseCurrent,USD,216000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OtherPrepaidExpenseCurrent,USD,182000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OtherPrepaidExpenseCurrent,USD,182000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OtherPrepaidExpenseCurrent,USD,204000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,OtherSundryLiabilitiesCurrent,USD,53000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,OtherSundryLiabilitiesCurrent,USD,41000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,OtherSundryLiabilitiesCurrent,USD,41000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,OtherSundryLiabilitiesCurrent,USD,46000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,PaymentsForRepurchaseOfCommonStock,USD,857000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,PaymentsForRepurchaseOfCommonStock,USD,3329000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,PaymentsForRepurchaseOfCommonStock,USD,526000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,PaymentsForRepurchaseOfCommonStock,USD,1153000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,PaymentsForRepurchaseOfCommonStock,USD,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,PaymentsToAcquireAvailableForSaleSecuritiesDebt,USD,12652000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,PaymentsToAcquireAvailableForSaleSecuritiesDebt,USD,11435000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,PaymentsToAcquireAvailableForSaleSecuritiesDebt,USD,1085000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,PaymentsToAcquireAvailableForSaleSecuritiesDebt,USD,3760000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,PaymentsToAcquireAvailableForSaleSecuritiesDebt,USD,2544000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,PaymentsToAcquireBusinessesNetOfCashAcquired,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,PaymentsToAcquireBusinessesNetOfCashAcquired,USD,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,PaymentsToAcquireBusinessesNetOfCashAcquired,USD,85000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,PaymentsToAcquireBusinessesNetOfCashAcquired,USD,85000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,PaymentsToAcquireBusinessesNetOfCashAcquired,USD,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,PaymentsToAcquireInProcessResearchAndDevelopment,USD,641000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,PaymentsToAcquireInProcessResearchAndDevelopment,USD,1100000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,PaymentsToAcquireInProcessResearchAndDevelopment,USD,86000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,PaymentsToAcquireInProcessResearchAndDevelopment,USD,301000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,PaymentsToAcquireInProcessResearchAndDevelopment,USD,8000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,PaymentsToAcquireNotesReceivable,USD,30000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,PaymentsToAcquireNotesReceivable,USD,40000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,PaymentsToAcquireNotesReceivable,USD,23000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,PaymentsToAcquireNotesReceivable,USD,23000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,PaymentsToAcquireNotesReceivable,USD,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,PaymentsToAcquirePropertyPlantAndEquipment,USD,284000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,PaymentsToAcquirePropertyPlantAndEquipment,USD,400000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,PaymentsToAcquirePropertyPlantAndEquipment,USD,113000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,PaymentsToAcquirePropertyPlantAndEquipment,USD,707000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,PaymentsToAcquirePropertyPlantAndEquipment,USD,196000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,PreferredStockParOrStatedValuePerShare,USD/shares,0.0001,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PreferredStockParOrStatedValuePerShare,USD/shares,0.0001,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,PreferredStockParOrStatedValuePerShare,USD/shares,0.0001,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,PreferredStockParOrStatedValuePerShare,USD/shares,0.0001,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,PreferredStockSharesAuthorized,shares,162000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PreferredStockSharesAuthorized,shares,162000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,PreferredStockSharesAuthorized,shares,162000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,PreferredStockSharesAuthorized,shares,162000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,PreferredStockSharesIssued,shares,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PreferredStockSharesIssued,shares,0.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,PreferredStockSharesIssued,shares,0.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,PreferredStockSharesIssued,shares,0.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,PreferredStockSharesOutstanding,shares,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PreferredStockSharesOutstanding,shares,0.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,PreferredStockSharesOutstanding,shares,0.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,PreferredStockSharesOutstanding,shares,0.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,PreferredStockValue,USD,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PreferredStockValue,USD,0.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,PreferredStockValue,USD,0.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,PreferredStockValue,USD,0.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,PrepaidExpenseAndOtherAssetsCurrent,USD,1195000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PrepaidExpenseAndOtherAssetsCurrent,USD,627000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,PrepaidExpenseAndOtherAssetsCurrent,USD,627000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,PrepaidExpenseAndOtherAssetsCurrent,USD,645000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,PrepaidTaxes,USD,187000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PrepaidTaxes,USD,0.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,USD,1338000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,USD,3151000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,USD,1360000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,USD,5575000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,USD,1573000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,USD,3105000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,USD,3548000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,USD,1957000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,USD,3206000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,USD,1285000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,ProceedsFromStockOptionsExercised,USD,112000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ProceedsFromStockOptionsExercised,USD,50000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ProceedsFromStockOptionsExercised,USD,25000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ProceedsFromStockPlans,USD,124000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ProceedsFromStockPlans,USD,65000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ProceedsFromStockPlans,USD,9000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,ProceedsFromStockPlans,USD,46000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ProceedsFromStockPlans,USD,15000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization,USD,658000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization,USD,433000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization,USD,433000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization,USD,465000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization,USD,2018000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization,USD,1945000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization,USD,1945000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization,USD,2063000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization,USD,2676000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization,USD,2378000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization,USD,2378000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization,USD,2528000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,ProvisionForDoubtfulAccounts,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ProvisionForDoubtfulAccounts,USD,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ProvisionForDoubtfulAccounts,USD,0.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ResearchAndDevelopmentExpense,USD,1991000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ResearchAndDevelopmentExpense,USD,3295000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ResearchAndDevelopmentExpense,USD,1131000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,ResearchAndDevelopmentExpense,USD,4845000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ResearchAndDevelopmentExpense,USD,1063000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,RestrictedCash,USD,12000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,RestrictedCash,USD,4000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,RestrictedCashCurrent,USD,0.0,,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021Q4I,MRNA
us-gaap,RestrictedCashCurrent,USD,0.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,RestrictedCashCurrent,USD,0.0,,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1I,MRNA
us-gaap,RestrictedCashCurrent,USD,17000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,RestrictedCashCurrent,USD,17000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,RestrictedCashNoncurrent,USD,12000000.0,,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021Q4I,MRNA
us-gaap,RestrictedCashNoncurrent,USD,12000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,RestrictedCashNoncurrent,USD,20000000.0,,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1I,MRNA
us-gaap,RestrictedCashNoncurrent,USD,4000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,RestrictedCashNoncurrent,USD,3000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,RestrictedStockExpense,USD,18000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,RestrictedStockExpense,USD,55000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,RestrictedStockExpense,USD,99000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,RetainedEarningsAccumulatedDeficit,USD,18320000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,RetainedEarningsAccumulatedDeficit,USD,13606000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,RetainedEarningsAccumulatedDeficit,USD,13606000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,RetainedEarningsAccumulatedDeficit,USD,12431000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,RevenueFromContractWithCustomerExcludingAssessedTax,USD,18471000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,RevenueFromContractWithCustomerExcludingAssessedTax,USD,19263000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,RevenueFromContractWithCustomerExcludingAssessedTax,USD,1862000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,RevenueFromContractWithCustomerExcludingAssessedTax,USD,6848000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,RevenueFromContractWithCustomerExcludingAssessedTax,USD,167000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability,USD,126000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability,USD,777000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability,USD,0.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,USD,72000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,USD,20000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,USD,714000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ShareBasedCompensation,USD,142000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ShareBasedCompensation,USD,226000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ShareBasedCompensation,USD,75000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,ShareBasedCompensation,USD,305000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ShareBasedCompensation,USD,101000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized,shares,47000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,shares,18980000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,USD/shares,33.34,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,USD,1600000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,USD,714000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,USD,413000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,shares,680000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,shares,4360000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,USD,3478000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,USD,1437000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,shares,24930000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,shares,25500000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,USD/shares,42.23,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,USD/shares,56.14,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,USD,59000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,shares,6520000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,USD/shares,122.5,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,USD/shares,8.13,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,USD/shares,130.23,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,USD/shares,113.03,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,USD,1378000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,ShortTermLeaseCost,USD,49000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ShortTermLeaseCost,USD,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ShortTermLeaseCost,USD,2000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,StockIssuedDuringPeriodSharesStockOptionsExercised,shares,3110000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,USD,12000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,USD,15000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,USD,21000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,StockIssuedDuringPeriodValueStockOptionsExercised,USD,112000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,StockIssuedDuringPeriodValueStockOptionsExercised,USD,50000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,StockIssuedDuringPeriodValueStockOptionsExercised,USD,9000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,StockIssuedDuringPeriodValueStockOptionsExercised,USD,25000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,StockIssuedDuringPeriodValueStockOptionsExercised,USD,15000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1,USD,143000000.0,,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021Q4I,MRNA
us-gaap,StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1,USD,2814000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1,USD,1667000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,StockRepurchasedDuringPeriodShares,shares,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,StockRepurchasedDuringPeriodValue,USD,857000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,StockRepurchasedDuringPeriodValue,USD,3329000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,StockRepurchasedDuringPeriodValue,USD,526000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,StockholdersEquity,USD,2561000000.0,,2020-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2020Q4I,MRNA
us-gaap,StockholdersEquity,USD,14145000000.0,,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021Q4I,MRNA
us-gaap,StockholdersEquity,USD,19123000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,StockholdersEquity,USD,19123000000.0,,2022-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,StockholdersEquity,USD,18863000000.0,,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,StockholdersEquity,USD,13854000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,StockholdersEquity,USD,13854000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,StockholdersEquity,USD,12817000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,TaxesPayableCurrent,USD,48000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,TaxesPayableCurrent,USD,63000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,TaxesPayableCurrent,USD,63000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,TaxesPayableCurrent,USD,52000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,TreasuryStockAcquiredAverageCostPerShare,USD/shares,245.76,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,TreasuryStockAcquiredAverageCostPerShare,USD/shares,142.83,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,TreasuryStockAcquiredAverageCostPerShare,USD/shares,143.26,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,TreasuryStockRetiredCostMethodAmount,USD,857000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,TreasuryStockRetiredCostMethodAmount,USD,3329000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,TreasuryStockRetiredCostMethodAmount,USD,1153000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,TreasuryStockSharesAcquired,shares,3000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,TreasuryStockSharesAcquired,shares,23000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,TreasuryStockSharesAcquired,shares,8000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,UnrecognizedTaxBenefits,USD,0.0,,2020-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2020Q4I,MRNA
us-gaap,UnrecognizedTaxBenefits,USD,68000000.0,,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021Q4I,MRNA
us-gaap,UnrecognizedTaxBenefits,USD,128000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,UnrecognizedTaxBenefits,USD,231000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023Q4I,MRNA
us-gaap,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,USD,1000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,USD,0.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities,USD,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities,USD,27000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,USD,54000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,USD,57000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,USD,44000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions,USD,14000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions,USD,4000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions,USD,86000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations,USD,0.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations,USD,0.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations,USD,0.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ValuationAllowanceDeferredTaxAssetChangeInAmount,USD,48000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,ValuationAllowanceDeferredTaxAssetChangeInAmount,USD,18000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,ValuationAllowanceDeferredTaxAssetChangeInAmount,USD,2069000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,ValueAddedTaxReceivableCurrent,USD,140000000.0,,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022Q4I,MRNA
us-gaap,ValueAddedTaxReceivableCurrent,USD,50000000.0,,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,,MRNA
us-gaap,ValueAddedTaxReceivableCurrent,USD,50000000.0,,2023-12-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,,MRNA
us-gaap,ValueAddedTaxReceivableCurrent,USD,36000000.0,,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1I,MRNA
us-gaap,VariableLeaseCost,USD,100000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,VariableLeaseCost,USD,165000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,VariableLeaseCost,USD,113000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,WeightedAverageNumberDilutedSharesOutstandingAdjustment,shares,28000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,WeightedAverageNumberDilutedSharesOutstandingAdjustment,shares,22000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,WeightedAverageNumberDilutedSharesOutstandingAdjustment,shares,19000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,WeightedAverageNumberDilutedSharesOutstandingAdjustment,shares,0.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,WeightedAverageNumberDilutedSharesOutstandingAdjustment,shares,0.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,WeightedAverageNumberOfDilutedSharesOutstanding,shares,431000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,WeightedAverageNumberOfDilutedSharesOutstanding,shares,416000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,WeightedAverageNumberOfDilutedSharesOutstanding,shares,405000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,WeightedAverageNumberOfDilutedSharesOutstanding,shares,382000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,WeightedAverageNumberOfDilutedSharesOutstanding,shares,382000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
us-gaap,WeightedAverageNumberOfSharesOutstandingBasic,shares,403000000.0,2021-01-01,2021-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2021,MRNA
us-gaap,WeightedAverageNumberOfSharesOutstandingBasic,shares,394000000.0,2022-01-01,2022-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2022,MRNA
us-gaap,WeightedAverageNumberOfSharesOutstandingBasic,shares,386000000.0,2023-01-01,2023-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2023Q1,MRNA
us-gaap,WeightedAverageNumberOfSharesOutstandingBasic,shares,382000000.0,2023-01-01,2023-12-31,0001682852-24-000015,2023,FY,10-K,2024-02-23,CY2023,MRNA
us-gaap,WeightedAverageNumberOfSharesOutstandingBasic,shares,382000000.0,2024-01-01,2024-03-31,0001682852-24-000027,2024,Q1,10-Q,2024-05-02,CY2024Q1,MRNA
